Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer

von Sridhar, Srikala S.
Veröffentlicht in Can Urol Assoc J (2019)

Efficacy and Tolerability of Lapatinib in the Management of Breast Cancer

von Rana, Punam, Sridhar, Srikala S.
Veröffentlicht 2012

New research in bladder cancer, ASCO-GU 2017

von Black, Peter C., Sridhar, Srikala
Veröffentlicht in Can Urol Assoc J (2017)

Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC)

von Humphreys, Michael R, Fernandes, Kimberly A, Sridhar, Srikala S
Veröffentlicht 2013

A case of isolated rectal recurrence of muscle invasive bladder cancer

von Kassam, Shaqil N., Aziz, Zared, Hung, Lick San, Sridhar, Srikala S.
Veröffentlicht 2013

Enfortumab Vedotin in urothelial cancer

von Alt, Marie, Stecca, Carlos, Tobin, Swanee, Jiang, Di Maria, Sridhar, Srikala S.
Veröffentlicht in Ther Adv Urol (2020)

A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens

von Elser, Christine, Sweet, Joan, Cheran, Sendhil K., Haider, Masoom A., Jewett, Michael, Sridhar, Srikala S.
Veröffentlicht 2012

Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials

von Wong, Sarah E., Quinn, David I., Bjarnason, Georg A., North, Scott A., Sridhar, Srikala S.
Veröffentlicht in Am J Clin Oncol (2020)

Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature

von Stecca, Carlos E., Alt, Marie, Jiang, Di Maria, Chung, Peter, Crook, Juanita M., Kulkarni, Girish S., Sridhar, Srikala S.
Veröffentlicht in Oncol Ther (2021)

The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers

von Vesprini, Danny, Narod, Steven A, Trachtenberg, John, Crook, Juanita, Jalali, Farid, Preiner, John, Sridhar, Srikala, Bristow, Robert G
Veröffentlicht 2011

Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO C...

von Seah, Jo-An, Blais, Normand, North, Scott, Rahim, Yasmin, Ruether, Dean, Black, Peter C., Zlotta, Alexandre R., Wood, Lori, Sridhar, Srikala S.
Veröffentlicht 2013

A Phase 2 Study of GW786034 (Pazopanib) with or without Bicalutamide in Patients with Castration Resistant Prostate Cancer

von Sridhar, Srikala S., Joshua, Anthony M., Gregg, Richard, Booth, Christopher M., Murray, Nevin, Golubovic, Jovana, Wang, Lisa, Harris, Pamela, Chi, Kim N.
Veröffentlicht in Clin Genitourin Cancer (2014)

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer

von Jiang, Di (Maria), Fyles, Anthony, Nguyen, Linh T., Neel, Benjamin G., Sacher, Adrian, Rottapel, Robert, Wang, Ben X., Ohashi, Pamela S., Sridhar, Srikala S.
Veröffentlicht in Oncotarget (2019)

Impact of ethnicity on the outcome of men with metastatic hormone sensitive prostate cancer

von Bernard, Brandon, Muralidhar, Vinayak, Chen, Yu-Hui, Sridhar, Srikala S., Mitchell, Edith, Pettaway, Curtis A., Carducci, Michael, Nguyen, Paul L., Sweeney, Christopher J.
Veröffentlicht in Cancer (2017)

Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada

von Hamilou, Zineb, North, Scott, Canil, Christina, Wood, Lori, Hotte, Sebastien, Sridhar, Srikala S., Soulières, Denis, Latour, Mathieu, Taussky, Daniel, Kassouf, Wassim, Blais, Normand
Veröffentlicht in Can Urol Assoc J (2020)

Transitioning to a New Normal in the Post-COVID Era

von Jiang, Di M., Berlin, Alejandro, Moody, Lesley, Kumar, Rajat, Hannon, Breffni, Krzyzanowska, Monika K., Dhani, Neesha, Cole, Heather, Elliott, Mary, Sridhar, Srikala S.
Veröffentlicht in Curr Oncol Rep (2020)

Prognostic Importance of Lymphovascular Invasion in Urothelial Carcinoma of the Renal Pelvis

von Danzig, Matthew R., Mallin, Katherine, McKiernan, James M., Stadler, Walter M., Sridhar, Srikala S., Morgan, Todd M., Bochner, Bernard H., Lee, Cheryl T.
Veröffentlicht in Cancer (2018)

Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel

von Yokom, Daniel W., Stewart, John, Alimohamed, Nimira S., Winquist, Eric, Berry, Scott, Hubay, Stacey, Lattouf, Jean-Baptiste, Leonard, Helene, Girolametto, Carla, Saad, Fred, Sridhar, Srikala S.
Veröffentlicht in Can Urol Assoc J (2018)

Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective

von Almatar, Ashraf, Richter, Suzanne, Lalani, Nafisha, Bender, Jackie L., Wiljer, David, Alkazaz, Nour, Legere, Laura, Maganti, Manjula, Sridhar, Srikala S., Catton, Pamela P., Jewett, Michael A.S.
Veröffentlicht in Can Urol Assoc J (2014)

Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone

von Saad, Fred, Winquist, Eric, Hubay, Stacey, Berry, Scott, Assi, Hazem, Levesque, Eric, Aucoin, Nathalie, Czaykowski, Piotr, Lattouf, Jean-Baptiste, Alloul, Karine, Stewart, John, Sridhar, Srikala S.
Veröffentlicht in Can Urol Assoc J (2016)